Loading...
BCX4430 – A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease
The adenosine nucleoside analog BCX4430 is a direct-acting antiviral drug under investigation for the treatment of serious and life-threatening infections from highly pathogenic viruses, such as the Ebola virus. Cellular kinases phosphorylate BCX4430 to a triphosphate that mimics ATP; viral RNA poly...
Na minha lista:
| Udgivet i: | J Infect Public Health |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
King Saud Bin Abdulaziz University for Health Sciences. Production and hosting by Elsevier Limited.
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937725/ https://ncbi.nlm.nih.gov/pubmed/27095300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiph.2016.04.002 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|